Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man

Borst, 2000, A family of drug transporters: the multidrug resistance-associated proteins, J. Natl. Cancer Inst., 92, 1295, 10.1093/jnci/92.16.1295 Cole, 1994, Pharmacological characterization of multidrug resistance MEP-transfected human tumour cells, Cancer Res., 54, 5902 Evers, 2000, Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport, Br. J. Cancer, 83, 366, 10.1054/bjoc.2000.1260 Ayrton, 2001, Role of transport proteins in drug absorption, Xenobiotica, 31, 469, 10.1080/00498250110060969 Kullak-Ublick, 2001, Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver, Gasteroenterology, 120, 525, 10.1053/gast.2001.21176 König, 2000, Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide, J. Biol. Chem., 275, 23161, 10.1074/jbc.M001448200 König, 2000, A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane, Am. J. Physiol., 278, G156 Schinkel, 1995, Multidrug resistance and the role of P-glycoprotein knockout mice, Eur. J. Cancer, 31A, 1295, 10.1016/0959-8049(95)00130-B Pastan, 1988, A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarised expression of P-glycoprotein in MDCK cells, Proc. Natl. Acad. Sci. U.S.A., 85, 4486, 10.1073/pnas.85.12.4486 Chen, 1999, Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter, Mol. Pharmacol., 56, 1219, 10.1124/mol.56.6.1219 Cui, 1999, Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells, Mol. Pharmacol., 55, 929 Evers, 1998, Drug export activity of the cloning of a rat liver Na+-independent organic anion transporter, Proc. Natl. Acad. Sci. U.S.A., 91, 133 Sugiyama, 2001, Characterisation of the efflux transport of 17β-estradiol-d-17β-glucuronide from the brain across the blood brain barrier, J. Pharmacol. Exp. Ther., 298, 316 Collins, 2001, Inter-species difference in drug properties, Chem. Biol. Interact., 134, 237, 10.1016/S0009-2797(01)00158-2 Vilei, 2001, Comparison of pig, human and rat hepatocytes as a source of liver specific function in culture systems—implications for use in bioartificial liver devices, Int. J. Artif. Organs, 24, 392, 10.1177/039139880102400609 Chen, 1990, Genomic organisation of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins, J. Biol. Chem., 265, 506, 10.1016/S0021-9258(19)40260-3 Grant, 1997, Analysis of intron–exon organisation of the human multidrug resistance protein (MRP) and alternative splicing of its mRNA, Genomics, 45, 368, 10.1006/geno.1997.4950 Tsujii, 1999, Exon–intron organisation of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin–Johnson syndrome, Gastroenterology, 117, 653, 10.1016/S0016-5085(99)70459-2 Cui, 2001, Vectorial transport by double transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2, Mol. Pharmacol., 60, 934, 10.1124/mol.60.5.934 Danzig, 1999, Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities, J. Pharmacol. Exp. Ther., 290, 854 Tsuruo, 1984, Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine, and adriamycin in drug-resistant tumour cells, Cancer Res., 44, 4303 Walgren, 2000, Efflux of dietary flavonoid quercetin 4β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2, J. Pharmacol. Exp. Ther., 294, 830 Oh D-M. Overview of membrane transport. In: Amidon GL, Sadee S, editors. Membrane transporters as drug targets? New York: Kluwer Academic Publishers; 1999, p. 1–25. Conrad, 2001, Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1, Toxicology, 156, 81, 10.1016/S0300-483X(00)00354-1 Müller, 1997, Molecular aspects of hepatobiliary transport, Am. J. Physiol., 272, G1203 Kool, 1997, Analysis of expression of cMOAT (MEP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines, Cancer Res., 57, 3537 Abe, 1999, Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1, J. Biol. Chem., 274, 17159, 10.1074/jbc.274.24.17159 Choudhuri, 2000, Cloning of the full-length coding sequence of rat liver-specific organic anion transporter-1 (r1st-1) and a splice variant and partial characterization of the rat 1st-1 gene, Biochem. Biophys. Res. Commun., 274, 79, 10.1006/bbrc.2000.3105 Zhang, 1998, Characterisation of P-glycoprotein mediated transport of KO2, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers, Pharmaceutical Res., 15, 1520, 10.1023/A:1011990730230 Wielinga, 1999, In vitro transepithelial drug transport by on-line measurement: cellular control of paracellular and transcellular transport, J. Pharm. Sci., 88, 1340, 10.1021/js980497z Scheffer, 2000, Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies, Cancer Res., 60, 5269